Link copied

10:35 | 15 May 2023

This is a weekly column about the five biggest funding rounds of the past week.

Last week was very weak for the venture capital market. Only one company raised a nine-figure sum.

UVeye, $100M.

Sector: Automotive.
UVeye, which develops automated vehicle inspection systems, raised $100 million in a Series D led by Hanaco VC. The Detroit-based startup’s platform uses a combination of proprietary algorithms, artificial intelligence, machine learning, sensors and more to detect external or mechanical defects in cars. Essentially, it performs a complete diagnosis of your car. The startup will use the new cash to start manufacturing UVeye inspection systems in North America, support further sales growth and expand its market. Founded in 2016, the company has raised nearly $196 million.

Amino Health, $80M.

Sector: health care.
San Francisco-based digital health advice company Amino Health has completed an $80 million round – a mix of equity and debt capital – led by Transformation Capital and Oxford Finance. The company’s platform allows users to digitally navigate to find quality and cost-effective and benefits. The startup now has 1.6 million customers. Founded in 2013, the company has raised $125 million.

8fig, $40M.

Sector: finance.
8fig, based in Austin, Texas, closed a $140 million Series B – $40 million in equity and $100 million in credit. The round was led by Koch Disruptive Technologies. The company offers growth plans for small to mid-sized e-commerce businesses with some sales experience. The plan includes financing and financial tools for supply chain management, financial planning, and shipping and logistics coordination. Since its founding, 8fig has provided more than $500 million to online sellers and last year increased its annual revenue by 800%. 8fig – founded in 2020 in Israel – to date, has raised $196.5 million.

Cullgen, $35M.

Sector: biotechnology.
San Diego-based Cullgen, which develops small molecule therapeutics, has raised $35 million in a Series C round led by the AstraZeneca-CICC Venture Capital Partnership. The company also raised an additional $5 million last week. The startup is developing new chemical compounds to treat what it calls “diseases without effective therapeutic approaches.” Founded in 2018, the company has raised a total of $106 million.

Petal, $35M.

Sector: fintech.
New York-based Petal closed a $35 million funding round led by Valar Ventures. This fintech company aims to help low-income consumers succeed financially. The company uses a proprietary cash-flow underwriting platform that serves as an alternative to traditional credit scores and makes credit more affordable. Founded in 2016, the company has raised more than $750 million.



We’ve summarized last week’s results and hope you found the information useful. Stay tuned for more information.

Head office

10:00 am - 7:00 pm

MON-FRI

V zářezu 902/8, Jinonice, 158 00 Praha 5

+420 255 790 513

Technical support

10:00 am - 12:00 pm

MON-FRI

[email protected]

+420 255 790 513